Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses?-Reference-Cited by-同舟云学术

Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses?

Published:2021-03 Issue:3 Volume:57 Page:106297
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Trentalange Alice^ORCID,Borgogno Enrica^ORCID,Motta Ilaria,Antonucci Miriam,Pirriatore Veronica,Costa Cecilia^ORCID,Rossi Giovanni,Barco Ambra^ORCID,De Nicolò Amedeo,Piccioni Pavilio,D'Avolio Antonio,Bonora Stefano,Di Perri Giovanni,Calcagno Andrea

Funder

Gilead Sciences

Cilag

Meso Scale Diagnostics

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference41 articles.

1. WHO. Global Tuberculosis Report 2019. Geneva: World Health Organization; 2019. www.who.int/tb/publications/global_report/en. [Accessed 7 June 2020].

2. Social determinants of therapy failure and multi drug resistance among people with tuberculosis: A review;Di Gennaro;Tuberculosis (Edinb),2017

3. Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?;Motta;Expert Opin Drug Metab Toxicol,2018

4. The Role of Therapeutic Drug Monitoring in Mycobacterial Infections;Peloquin;Microbiol Spectr,2017

5. Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin;Gumbo;Antimicrob Agents Chemother,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis;European Journal of Drug Metabolism and Pharmacokinetics;2024-08-17

2. Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine;Infection;2024-02-08

3. Variability in plasma rifampicin concentrations and role of SLCO1B1 , ABCB1 , AADAC2 and CES2 genotypes in Ethiopian patients with tuberculosis;Infectious Diseases;2024-02-05

4. Clinical efficacy of dexamethasone combined with isoniazid in the treatment of tuberculous meningitis and its effect on peripheral blood T cell subsets;Open Medicine;2024-01-01

5. Tuberculosis treatment outcomes among precarious patients in France;Infectious Diseases Now;2022-10